Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

November 2022 | 127 pages | ID: HBC7FDDCD6FFEN
Prodture

Abstracts

The global human microbiome therapeutic market is expected to grow at a CAGR of around 42.1% during 2023-2030. This report on global human microbiome therapeutic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global human microbiome therapeutic market by segmenting the market based on technology, therapeutic area, type, and region. Also, detailed profiles of companies operating in the human microbiome therapeutic market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Human Microbiome as a Validated Target for Drug Development
• Increasing Focus on Human Microbiome Therapeutics Development
• Increasing Collaboration Between Public-Private Organizations

Market Challenges

• Stringent Government Regulations
• Lack of Expertise and Adequate Research

Historical & Forecast Period

Base Year: 2022

Historical Period: 2018-2022

Forecast Period: 2023-2030

Market by Technology

• Genomics
• Proteomics
• Metabolomics

Market by Route of Therapeutic Area

• Neurological Disorders
• Dermatological Indications
• Cancers
• Metabolic Disorders
• Gastrointestinal Disorders
• Others

Market by Type

• Probiotics and Prebiotics
• Medical Food
• Diagnostic Tests
• Others

Market by Region

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East & Africa

Contents

1. PREFACE

1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
  1.4.1 Phase I
  1.4.2 Phase II
  1.4.3 Phase III
1.5 Assumptions

2. KEY INSIGHTS

3. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET

3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET ANALYSIS

4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Geonomics
5.3. Proteomics
5.4. Metabolomics

6. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET BY THERAPEUTIC AREA

6.1 Introduction
6.2 Neurological Disorders
6.3 Dermatological Indications
6.4 Cancers
6.5 Metabolic Disorders
6.6 Gastrointestinal Disorders
6.7 Others

7. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET BY TYPE

7.1 Introduction
7.2 Prebiotics and Probiotics
7.3 Medical Food
7.4 Diagnostic Tests
7.5 Others

8. GLOBAL HUMAN MICROBIOME THERAPEUTIC MARKET BY REGION

8.1 Introduction
8.2 Europe
8.3 North America
8.4 Asia Pacific
8.5 Latin America
8.6 Middle East & Africa

9. SWOT ANALYSIS

10. PORTER’S FIVE FORCES

11. MARKET VALUE CHAIN ANALYSIS

12. COMPETITIVE LANDSCAPE

12.1 Competitive Scenario
12.2 Company Profiles
  12.2.1 Bristol-Myers Squibb
  12.2.2 Dow Inc Chemical
  12.2.3 Takeda Pharmaceutical Company Limited
  12.2.4 Johnson & Johnson
  12.2.5 DuPont de Nemours, Inc.
  12.2.6 Merck & Co. Inc.
  12.2.7 Pfizer Inc.
  12.2.8 Vertex Pharmaceuticals
  12.2.9 Evelo Biosciences, Inc.
  12.2.10 Kaleido Biosciences, Inc.
  12.2.11 Seres Therapeutics, Inc.
  12.2.12 PureTech Health PLC

List Of Tables

LIST OF TABLES

Table 1: Global Human Microbiome Therapeutic Market Portraiture
Table 2: Global Human Microbiome Therapeutic Market by Technology (in US$ Million), 2022 & 2030
Table 3: Global Human Microbiome Therapeutic Market by Therapeutic Area (in US$ Million), 2022 & 2030
Table 4: Global Human Microbiome Therapeutic Market by Type (in US$ Million), 2022 & 2030
Table 5: Global Human Microbiome Therapeutic Market by Region (in US$ Million), 2022 & 2030
Table 6: List of Key Players

List Of Figures

LIST OF FIGURES

Figure 1: Global Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 2: Global Human Microbiome Therapeutic Market by Technology, 2022
Figure 3: Global Human Microbiome Therapeutic Market by Therapeutic Area, 2022
Figure 4: Global Human Microbiome Therapeutic Market by Type, 2022
Figure 5: Global Human Microbiome Therapeutic Market by Region, 2022
Figure 6: Global Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 7: Global Human Microbiome Therapeutic Market by Technology (in %), 2022 & 2030
Figure 8: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 9: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 10: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 11: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 12: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 13: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 14: Global Human Microbiome Therapeutic Market by Therapeutic Area (in %), 2022 & 2030
Figure 15: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 16: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 17: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 18: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 19: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 20: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 21: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 22: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 23: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 24: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 25: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 26: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 27: Global Human Microbiome Therapeutic Market by Type (in %), 2022 & 2030
Figure 28: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 29: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 30: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 31: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 32: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 33: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 34: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 35: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 36: Global Human Microbiome Therapeutic Market by Region (in %), 2022 & 2030
Figure 37: Europe Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 38: Europe Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 39: North America Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 40: North America Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 41: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 42: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 43: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 44: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 45: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 46: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 47: Market Value Chain